Why doctors may pay scant attention to medicine safety warnings
Scepticism about regulators' independence and poor integration of safety information into clinical practice are contributors, researchers find
The vague terms of post-market drug safety warnings from the TGA and other watchdogs mean they only have small effects on doctors’ prescribing habits, researchers say.
A meta-analysis has found that safety warnings on specific drugs led to only a 6% reduction in the prescribing rate on average, said the international research team, led by Associate Professor Barbara Mintzes from the University of Sydney.
